スマートフォン認知行動療法がうつ病発症を長期予防 ─1年間追跡で実証(British Journal of Psychiatry)

ad

2026-06-01 名古屋市立大学

名古屋市立大学、京都大学らの共同研究グループは、閾値下うつ状態にある一般成人3,280人を対象とした完全オンラインのランダム化比較試験(RESiLIENT試験)において、スマートフォンアプリを用いた認知行動療法(CBT)が1年間にわたりうつ病発症を予防することを実証した。研究では、行動活性化(BA)、認知再構成(CR)、問題解決(PS)、アサーション(AT)、睡眠行動療法(BI)の5つのCBTスキルを単独または組み合わせて提供した。その結果、すべての介入群でうつ病発症率が低下し、特に「行動活性化+アサーション(BA+AT)」「行動活性化+認知再構成(BA+CR)」「睡眠行動療法(BI)」では発症率を約40~50%抑制した。また、50週間にわたる抑うつ症状の累積量である「うつ病総負荷(Total Burden of Depression)」を世界で初めて評価し、全介入が総負荷を有意に軽減することを確認した。特にBA+CRが最も高い効果を示した。本成果は、専門家による対面治療を必要としないスマホCBTが長期的なうつ病一次予防に有効であることを示し、今後のデジタルメンタルヘルスやAIによる個別化介入の基盤となる重要な知見を提供している。

スマートフォン認知行動療法がうつ病発症を長期予防 ─1年間追跡で実証(British Journal of Psychiatry)

<関連情報>

軽度うつ病の成人における大うつ病予防のための認知行動スキル:スマートフォンを用いた認知行動療法(CBT)無作為化試験(RESiLIENT試験)の50週間追跡分析 Cognitive and behavioural skills to prevent major depression among adults with subthreshold depression: 50-week follow-up analysis of smartphone CBT randomised trials (RESiLIENT trial)

Tatsuo Akechi,Hisashi Noma,Aran Tajika,Rie Toyomoto,Masatsugu Sakata,Yan Luo,Masaru Horikoshi,Norito Kawakami,Takeo Nakayama and Naoki Kondo,…
The British Journal of Psychiatry  Published:01 June 2026
DOI:https://doi.org/10.1192/bjp.2026.10630

Abstract

Background

Major depression is a common and disabling disorder, and individuals with subthreshold depression represent a key at-risk group. We previously demonstrated that specific cognitive behavioural therapy (CBT) skills training delivered via a smartphone app (behavioural activation, cognitive restructuring, problem solving, assertion training and behavioural therapy for insomnia) improved depressive symptoms for up to 26 weeks.

Aims

To evaluate the long-term effects (up to 50 weeks) of CBT skills and their combinations for preventing major depressive episodes and reducing the total burden of depression (TBD).

Method

Participants were adults from the general population with subthreshold depression. A master protocol trial with four 2 × 2 factorial trials was used to randomise 3280 participants to one of nine intervention arms or a self-check control group. The primary outcome was time to onset of major depression by week 50.

Results

Hazard ratios for the interventions ranged from 0.52 (95% CI: 0.29–0.94) to 0.63 (95% CI: 0.36–1.10), with behavioural activation + assertion training showing the greatest preventive effect (number needed to treat: 23.3 (95% CI: 12.2 to 250)), followed by behavioural therapy for insomnia, behavioural activation + behavioural therapy for insomnia and cognitive restructuring. All interventions reduced TBD scores compared with control, with behavioural activation + cognitive restructuring exhibiting the largest reduction. Effect sizes at week 50 ranged from −0.34 to −0.07 and behavioural activation + cognitive restructuring was the most effective. No serious adverse events were reported.

Conclusions

The current findings indicated that specific CBT skills – particularly behavioural activation +assertion training , behavioural activation + cognitive restructuring and behavioural therapy for insomnia – effectively prevented the onset of depression and reduced the TBD at 50 weeks. Given its brevity, portability, accessibility and scalability, smartphone-based CBT is promising as a preventive intervention.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました